Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 362

1.

A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.

Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W.

Gastroenterology. 2009 Jul;137(1):165-75. doi: 10.1053/j.gastro.2009.03.041. Epub 2009 Mar 26.

PMID:
19328798
2.

Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.

Pendás-Franco N, Aguilera O, Pereira F, González-Sancho JM, Muñoz A.

Anticancer Res. 2008 Sep-Oct;28(5A):2613-23. Review.

3.

Tgf-beta signaling alterations and colon cancer.

Bellam N, Pasche B.

Cancer Treat Res. 2010;155:85-103. doi: 10.1007/978-1-4419-6033-7_5. Review.

PMID:
20517689
4.
5.

beta-Catenin signaling in biological control and cancer.

Gavert N, Ben-Ze'ev A.

J Cell Biochem. 2007 Nov 1;102(4):820-8. Review.

PMID:
17854061
6.

Wnt/FZD signaling and colorectal cancer morphogenesis.

Hlubek F, Spaderna S, Schmalhofer O, Jung A, Kirchner T, Brabletz T.

Front Biosci. 2007 Jan 1;12:458-70. Review.

PMID:
17127310
8.

Ectopic expression of mucins in colorectal cancer metastasis.

Irimura T, Matsushita Y, Hoff SD, Yamori T, Nakamori S, Frazier ML, Giacco GG, Cleary KR, Ota DM.

Semin Cancer Biol. 1991 Apr;2(2):129-39. Review.

PMID:
1680492
9.

TGFbeta and Wnt pathway cross-talk.

Attisano L, Labbé E.

Cancer Metastasis Rev. 2004 Jan-Jun;23(1-2):53-61. Review.

PMID:
15000149
10.
11.

Guanylyl cyclase C: a molecular marker for staging and postoperative surveillance of patients with colorectal cancer.

Frick GS, Pitari GM, Weinberg DS, Hyslop T, Schulz S, Waldman SA.

Expert Rev Mol Diagn. 2005 Sep;5(5):701-13. Review.

PMID:
16149873
12.

Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells.

Gouyer V, Fontaine D, Dumont P, de Wever O, Fontayne-Devaud H, Leteurtre E, Truant S, Delacour D, Drobecq H, Kerckaert JP, de Launoit Y, Bracke M, Gespach C, Desseyn JL, Huet G.

Oncogene. 2008 Jul 3;27(29):4024-33. doi: 10.1038/onc.2008.42. Epub 2008 Mar 3. Review.

PMID:
18317448
13.

Biology of colorectal cancer.

Saif MW, Chu E.

Cancer J. 2010 May-Jun;16(3):196-201. doi: 10.1097/PPO.0b013e3181e076af. Review.

PMID:
20526096
14.

The potential role of gene expression in the management of primary and metastatic colorectal cancer.

Alvarado MD, Jensen EH, Yeatman TJ.

Cancer Control. 2006 Jan;13(1):27-31. Review.

15.

MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.

Shi M, Guo N.

Cancer Treat Rev. 2009 Jun;35(4):328-34. doi: 10.1016/j.ctrv.2008.12.002. Epub 2009 Jan 25. Review.

PMID:
19171434
16.

L1-CAM in cancerous tissues.

Gavert N, Ben-Shmuel A, Raveh S, Ben-Ze'ev A.

Expert Opin Biol Ther. 2008 Nov;8(11):1749-57. doi: 10.1517/14712598.8.11.1749 . Review.

PMID:
18847309
17.

Wnt-beta-catenin signaling in the pathogenesis of osteoarthritis.

Corr M.

Nat Clin Pract Rheumatol. 2008 Oct;4(10):550-6. doi: 10.1038/ncprheum0904. Review.

PMID:
18820702
18.

Wnt signaling and prostate cancer.

Robinson DR, Zylstra CR, Williams BO.

Curr Drug Targets. 2008 Jul;9(7):571-80. Review.

PMID:
18673243
19.

Importance of Wnt signaling in the tumor stroma microenvironment.

Macheda ML, Stacker SA.

Curr Cancer Drug Targets. 2008 Sep;8(6):454-65. Review.

PMID:
18781892
20.

APC dosage effects in tumorigenesis and stem cell differentiation.

Gaspar C, Fodde R.

Int J Dev Biol. 2004;48(5-6):377-86. Review.

Supplemental Content

Support Center